- Home
- GOSS vs AEVA Comparison
GOSS vs AEVA Comparison
Compare GOSS & AEVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GOSS
- AEVA
- Stock Information
- Founded
- GOSS 2015
- AEVA 2019
- Country
- GOSS United States
- AEVA United States
- Employees
- GOSS N/A
- AEVA 301
- Industry
- GOSS Biotechnology: Pharmaceutical Preparations
- AEVA Auto Parts:O.E.M.
- Sector
- GOSS Health Care
- AEVA Consumer Discretionary
- Exchange
- GOSS Nasdaq
- AEVA Nasdaq
- Market Cap
- GOSS 212.9M
- AEVA 201.0M
- IPO Year
- GOSS 2019
- AEVA N/A
- Fundamental
- Price
- GOSS $0.74
- AEVA $3.75
- Analyst Decision
- GOSS Strong Buy
- AEVA Buy
- Analyst Count
- GOSS 5
- AEVA 5
- Target Price
- GOSS $9.20
- AEVA $10.53
- AVG Volume (30 Days)
- GOSS 881.6K
- AEVA 341.1K
- Earning Date
- GOSS 11-07-2024
- AEVA 11-06-2024
- Dividend Yield
- GOSS N/A
- AEVA N/A
- EPS Growth
- GOSS N/A
- AEVA N/A
- EPS
- GOSS N/A
- AEVA N/A
- Revenue
- GOSS $105,322,000.00
- AEVA $7,980,000.00
- Revenue This Year
- GOSS N/A
- AEVA $110.92
- Revenue Next Year
- GOSS N/A
- AEVA $108.75
- P/E Ratio
- GOSS N/A
- AEVA N/A
- Revenue Growth
- GOSS N/A
- AEVA 176.22
- 52 Week Low
- GOSS $0.50
- AEVA $2.20
- 52 Week High
- GOSS $1.60
- AEVA $7.25
- Technical
- Relative Strength Index (RSI)
- GOSS 22.63
- AEVA 46.47
- Support Level
- GOSS $0.78
- AEVA $4.03
- Resistance Level
- GOSS $0.92
- AEVA $4.43
- Average True Range (ATR)
- GOSS 0.05
- AEVA 0.32
- MACD
- GOSS -0.01
- AEVA -0.07
- Stochastic Oscillator
- GOSS 0.00
- AEVA 14.95
About GOSS Gossamer Bio Inc.
Gossamer Bio Inc is a clinical-stage biopharmaceutical company. It focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology. The company pipeline products include Seralutinib, which address the cellular overgrowth, fibrosis, and vascular remodeling which underlie PAH (pulmonary arterial hypertension); GB004, for the treatment of inflammatory bowel disease, including ulcerative colitis and Crohn's disease; GB1275, for the treatment of oncology indications; and GB001, for the treatment of moderate-to-severe eosinophilic asthma.
About AEVA Aeva Technologies Inc.
Aeva Technologies Inc through its Frequency Modulated Continuous Wave (FMCW) sensing technology, designs a 4D LiDAR-on-chip that, along with its proprietary software applications, has the potential to enable the adoption of LiDAR across broad applications from automated driving to consumer electronics, consumer health, industrial automation, and security application. The company operates in North America, EMEA, and Asia. The company derives the majority of its revenue from North America.